Cone-Rod Dystrophies
|
0.310 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
|
|
|
Disorder of eye
|
0.300 |
Biomarker
|
group |
GENOMICS_ENGLAND |
|
|
|
Disorder of eye
|
0.300 |
Biomarker
|
group |
GENOMICS_ENGLAND |
|
|
|
T-Lymphocytopenia, Idiopathic CD4-Positive
|
0.300 |
Biomarker
|
disease |
CTD_human |
|
|
|
Lymphopenia
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Color vision defect
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Immunologic Deficiency Syndromes
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Nyctalopia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Pneumonia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Photophobia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Bronchiolitis Obliterans Organizing Pneumonia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Recurrent sinusitis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Recurrent otitis media
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Abnormality of retinal pigmentation
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Visual Impairment
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Recurrent shingles
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Retinal Diseases
|
0.020 |
Biomarker
|
group |
BEFREE |
Given its strong degree of evolutionary conservation and abundant and nearly exclusive expression in photoreceptors, it is likely that UNC-119 plays an important role in vision and is a strong candidate gene for retinal diseases that map to 17q11.2.
|
9761287 |
1998 |
Retinitis Pigmentosa
|
0.310 |
Biomarker
|
disease |
CTD_human |
HRG4 (UNC119) mutation found in cone-rod dystrophy causes retinal degeneration in a transgenic model.
|
11006213 |
2000 |
Cone-Rod Dystrophy 2
|
0.310 |
GermlineCausalMutation
|
disease |
ORPHANET |
HRG4 (UNC119) mutation found in cone-rod dystrophy causes retinal degeneration in a transgenic model.
|
11006213 |
2000 |
Retinal Diseases
|
0.020 |
GeneticVariation
|
group |
BEFREE |
HRG4 was screened for mutations in patients with various retinopathies, and a transgenic mouse model was constructed and analyzed based on a mutation found.
|
11006213 |
2000 |
Cone-Rod Dystrophy 2
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
A heterozygous truncation mutation in HRG4 was found in a patient with late onset cone-rod dystrophy, and a transgenic (TG) mouse expressing the identical mutant protein developed late onset retinal degeneration, confirming the pathogenic potential of HRG4.
|
17174953 |
2007 |
Cone-Rod Dystrophies
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
A heterozygous truncation mutation in HRG4 was found in a patient with late onset cone-rod dystrophy, and a transgenic (TG) mouse expressing the identical mutant protein developed late onset retinal degeneration, confirming the pathogenic potential of HRG4.
|
17174953 |
2007 |
Photoreceptor degeneration
|
0.020 |
Biomarker
|
disease |
BEFREE |
Recently, the dominant negative pathogenic mechanism in the TG model was shown to involve increased affinity of the truncated mutant HRG4 for its target, ARL2, which leads to a delayed decrease in its downstream target, mitochondrial ANT1, mitochondrial stress, synaptic degeneration, trans-synaptic degeneration, and whole photoreceptor degeneration by apoptosis.
|
17174953 |
2007 |
Lung diseases
|
0.010 |
AlteredExpression
|
group |
BEFREE |
Using primary lung fibroblasts from patients with fibrotic lung diseases and control subjects, we show that the expression of alpha-smooth muscle actin is highly correlated with that of Unc119.
|
17579091 |
2007 |
LATE-ONSET RETINAL DEGENERATION (disorder)
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
A heterozygous truncation mutation in HRG4 was found in a patient with late onset cone-rod dystrophy, and a transgenic (TG) mouse expressing the identical mutant protein developed late onset retinal degeneration, confirming the pathogenic potential of HRG4.
|
17174953 |
2007 |